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ABSTRACT 
A dUTPase is a crucial enzyme that hydrolyzes dUTP to dUMP. This reaction 
prevents the mutagenic or lethal misincorporation of uracil into DNA. For that reason, the 
enzyme is required for efficient DNA replication. Previous studies have shown that 
ORFl l has dUTPase-like motifs and thus may be a dUTPase. Generally, 
gammaherpesviruses contain six characteristic dUTPase motifs. In particular ORFl 1 
contains motifs 1, 2, 4, and 6. While the characteristic motifs of gamroaberpesviruses 
include motifs 1, 2, 3, 4, 5, and 6, the number of dUTPase-like motifs in ORFl 1 's protein 
sequence is substantial. Thus, ORFl 1 may be a dUTPase. To further investigate this 
hypothesis, ORFl 1 was cloned, expressed in E. coli, and the protein was examined in a 
dUTPase assay. ORFl 1 was cloned into pGEX-5x-3 through a sequential process starting 
with a polymerase chain reaction (PCR) and ending with the isolation of plasmid DNA 
containing ORFl 1. The positive clones were sequenced and confirmed. Subsequently, 
ORFl 1 was expressed as a GST fusion protein in E. coli. Verification of expression was 
done by purifying the GST proteins using glutathione beads. The purified proteins were 
evaluated by SOS-PAGE. The SOS-PAGE demonstrated purification of proteins with 
their expected sizes. Finally, the lack of dUTPase activity was demonstrated by a 
dUTPase assay. Bacterial extracts expressing ORFl 1 were incubated with dUTP and the 
separation of nucleotides was evaluated using thin layer chromatography. In summary, 
our results demonstrate that Kaposi's sarcoma-associated herpesvirus ORFl 1 does not 
code for a functional dUTPase. Further studies are needed to determine the function of 
the protein. 
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INTRODUCTION 
Kaposi's sarcoma, also known as KS, was identified in 1872 by Moritz Kaposi, a 
Hungarian dermatologist. He described the disease as an angiomatous neoplasm that 
affected men ofltalian, Jewish or Mediterranean descent (Dounnishev et al., 2003). 
Though the disease's characteristics were identified during this time not much was 
known about the causitive agent. It was not until 1994, when scientists from the 
Department of Pathology in Columbia University isolated fragments of a genome from 
the lesion of a Kaposi's sarcoma patient with AIDS. The scientists found that the 
sequences were homologous to several genes of the Gammaherpesvirinae sub-family 
(Chang et al., 1994). The isolated genome was then completely sequenced in 1996 
(Russo et al., 1996). Kaposi's sarcoma-associated herpesvirus (KSHV), also known as 
humanherpesvirus 8 (HHV-8), was found to be the causative agent of Kaposi's sarcoma 
(Ambroziak et al., 1995). Although scientists have advanced significantly since 1872 in 
identification of the virus and several of its mechanisms, there are still several unknown 
factors of the virus. These unknown factors include understanding latency, transmission, 
specific interaction with HIV, sex preference, and unknown functions of a number of 
viral genes. 
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KSHV belongs to the Gammaherpesvirinae sub-family and is the first known 
human Rhadinovirus (Knipe & Howley, 2007). Also, in the same sub-family is Epstein­ 
Barr virus (EBV), which was found to be homologous to KSHV. KSHV is the causative 
agent of primary effusion lymphoma (Cesarman et al., 1995), some instances of 
multicentric Castleman's disease (Soulier et al., 1995), and Kaposi's sarcoma(Chang et 
al., 1994). In the United States, the virus infects less than 5% of the population. In the 
Mediterranean and Europe, it infects 5o/o-20% and in Africa it infects greater than 50% of 
the population (Knipe & Howley, 2007). In the US, KSHV is mostly seen in patients 
whose immune system has been compromised, such as AIDS patients. However, not 
much is known about the correlation between HIV and KSHV. 
KSHV's gene expression and replication is similar to that of EBV (Knipe & 
Howley, 2007). However, they differ greatly in their latency programs. The gene 
expression of the herpesviruses involves latent, immediate-early, early, and late gene 
transcription. Immediate-early genes code for transcription factors and play an important 
role in initiating lytic gene expression leading to viral replication. The early genes are 
involved with DNA replication and the late genes are involved with packaging the virus 
(Lacoste et al., 2004). KSHV has a genome about 165 kbp long. Its genome codes for 
several cellular homologous proteins. These include IL-6, bcl-Z, DNA polymerase, G­ 
protein coupled receptor, uracil-DNA glycosylase (UNG), and dUTPase (Russo et al., 
1996). 
One essential protein of the virus is a dUTPase. A dUTPase is an enzyme that 
prevents the misincorporation of uracil into DNA. It does this by maintaining a low ratio 
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of dUTP/dTIP (Chen et al., 2002). Uracil can be incorporated into DNA by 
rnisincorporation of dUTP or by the dearnination of cytosine. dUTPases exist in several 
herpesviruses. However, it is not clear why the virus needs this enzyme if the cell already 
contains it. Toe importance of dUTPases may be due to the ability ofherpesviruses to 
replicate in non-dividing cells. Toe lack of the dUTPase gene in lentiviruses has been 
shown to show a defect in the replication of non-dividing cells (Turelli et al., 1997). In 
another gammaherpesvirus, EBV, the dUTPase of the virus was shown to be essential in 
non-dividing cells as well (Fleischmann et al., 2002). Therefore, dUTPases are required 
for efficient DNA replication in several herpesviruses. 
Due to the importance of dUTPases in herpesviruses, it has been suggested that 
dUTPases may be a potential target for chemotherapy (Studebaker et al., 2001). 
Currently, there are a few drugs which are used to target herpesviruses. These include 
acyclovir, famciclovir, ganciclovir, idoxuridine, valacyclovir, trifluorothyrnidine, and 
foscarnet. Specifically, ganciclovir and foscamet are used to treat patients with KSHV 
(Porter, 2006). These drugs act on the DNA polymerase of the virus and inhibit DNA 
replication (Studebaker et al., 2001). Consequently, drug resistance is becoming a 
problem with these drugs and new targets must be developed (Studebaker et al., 2001 ). 
Gammaherpesviruses have six characteristic dUTPase motifs. These motifs are 
termed 1, 2, 3, 4, 5 and 6. On the other hand, human dUTPases contain the characteristic 
motifs 1-5 and exist as trimers as opposed to herpesvirus dUTPases which exist as 
monomers (Tarbouriech et al., 2005). The protein structure differences between human 
and herpesvirus dUTPases coincide with the gene length of both. Generally, the gene that 
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codes for dUTPases in herpesviruses is approximately double the size of the human gene 
(McOeehan et al., 2001 ). Specifically, human, E. coli, and S. cerevisiae dUTPases are 
141, 150, and 147 residues long, respectively, and exist as monomers (Mcintosh et al., 
1992). On the contrary, herpesvirus dUTPases range from 318 residues to 388 residues in 
length (Kremmer et al., 1999; McGeehan et al., 2001 ). Although both enzymes differ 
greatly, they both have the same function. 
There is one known functional dUTPase that is coded by KSHV, ORF54 
(Kremmer et al., 1999). However, KSHV ORFl 1 has been suggested to be a putative 
dUTPase (Davidson et al., 2005) because it contains gammaherepesvirus dUTPase-like 
motifs I, 2, 4 and 6. In order to further investigate this hypothesis, ORF! 1 was cloned, 
expressed as a OST fusion protein, and assayed for dUTPase activity. 
ORFl 1 was cloned into pGEX-5x-3 and expressed in E.coli BL21 cells. The 
expressed OST fusion proteins were purified for verification. Finally, the protein extracts 
were assayed for dUTPase activity and visualized by thin layer chromatography. Our 
findings show that ORF! 1 does not code for a functional dUTPase and further studies are 
needed to determine the function of ORF! 1. 
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MATERIALS AND METIIODS 
Sequence Alignment 
KSHV ORFl l and ORF54 were aligned using ClustalW2 
(http://www.ebi.ac.uk/clustalw21). The accession numbers used for the alignments were 
AAC57088 for ORFl l and AAB62631 for ORF54. They were manually aligned and 
characteristic dUTPase motifs l, 2, 6 and 4 were designated according to Davidson et al. 
(2005). 
Cloning KSHV ORFl 1 
KSHV ORFl l was cloned into pGEX-5x-3 (GE Healthcare), a GST vector, for 
protein expression and characterization studies. ORFI I was amplified via the polymerase 
chain reaction using BCBL-1 genomic DNA as the template. Twenty five cycles of the 
following conditions were used to amplify the gene: 94°C, 2 m; 94°C, 30 s; 54°C, 30 s; 
68°C, 2 m. The primer set used is: Forward­ 
AAGGATCCAAGCGCAGGAGTCAGAGCAG and 
reverse-AAGAATTCCTAACTGCGTCCGGTGGC. The final reaction volume was 
50 uL in a IX reaction buffer which consisted of 1.75 mM MgCh, 50 ng BCBL-1 
template DNA, 25 pmol of each primer, and Fideli Taq polymerase (USB). 
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Following PCR, the product was gel purified using a QIAquick Gel Extraction Kit 
(Qiagen). The purified product and the pGEX vector were singly digested with Barn HI 
(Promega) and Eco RI (Promega) respectively. Additionally, the vector was treated with 
Thermosensitive Alkaline Phosphatase (Promega). All of the digests were heat 
inactivated and purified using Charge Switch Kit (lnvitrogen) before ligation. The 
ligation reaction volume was 20 uL in a lX Ligase Buffer Mix containing T4 DNA 
Ligase (Promega), ORF! l , and pGEX purified digest products. Another ligation reaction 
without ORFI 1 was done as the control. The reaction was incubated overnight at 4°C. 
The ligation was then transformed into Escherichia coli (E. coli) DH5a cells. The 
transformation is described in further detail in the next section. Ten colonies from the 
transformation were grown in Luria Broth and ampicillin (100 ug/uL) overnight at 37°C. 
Plasmid DNA was isolated using Quantum Prep Plasmid Mini-prep Kit (Bio Rad). The 
isolated DNA was digested using the previously stated restriction enzymes to verify the 
presence of an insert. The presumed positive clones were sent to be sequenced at Mclab 
(San Francisco, CA). 
Transformation 
E. coli DH5a and E. coli BL21 (DE3) pLysS competent cells were made 
according to Sambrook and Russell (2000). The competent cells were gently mixed and 
aliquoted at 50 uL in each tube. Two aliquots of competent cells were used for the 
transformation. Frozen E. coli DH5a competent cells were thawed on ice. Then, 5 uL of 
the ligation reactions were added to the aliquots. The ligations were transformed into E. 
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coli DH5a cells. As a control, 1 uL of the parental plasmid was added to an aliquot as 
well. The cells were mixed and incubated on ice for thirty minutes. Next, the cells were 
incubated at 42°C for ninety seconds and rested on ice for two minutes. Afterward, 
950 uL of room temperature Luria Broth media was added to each tube and cells were 
incubated at 37°C for one hour in a water bath. The cells were then plated on Luria Broth, 
agar and ampicillin (100 ug/uL) plates and incubated overnight at 37°C. 
Expression and Purification ofKSHV ORFI I 
The isolated pGEX-ORFI l DNA and pGEX-NdUTPase (human dUTPase) were 
transformed into E. coli BL2l (DE3) pLysS expression cells using the protocol described 
in the transformation section. pGEX-NdUTPase was graciously provided by Dr. Patrizia 
Caposio and colleagues from the Department of Public Health and Microbiology at the 
University of Torino, Italy (Caposio et al., 2004). This plasmid contains the human 
nuclear form dUTPase and was used as a positive control. 
Following transformation, the colonies were picked and grown overnight at 28°C 
in IO mL Luria Broth, ampicillin (100 ug/uL), and 0.5% glucose. Then, 9 mL of 
overnight cultures were inoculated into 95 mL of Luria Broth, 5 mL of glucose (0.46%), 
and ampicillin (I OOug/uL) and grown at 28°C. The cultures were grown to an optical 
density of 0.5 and induced with 0.5 mM IPTG for one hour. The 100 mL was separated 
into two aliquots of 50 mL; one was used in protein purification and the other was used in 
the dUTPase assay. The cells were harvested at 4°C, 10,000 r.p.m. for ten minutes. The 
cells were lysed in 3 mL of buffer (20 mM HEPES, I 00 mM NaCl, 5 mM MgCli, 0.01 % 
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Igepal). The cells were sonicated three times for fifteen seconds with a ten second rest on 
ice in between. Samples were spun down at 4°C, 10,000 r.pm. for fifteen minutes. The 
supernatant was collected in 3 mL aliquots. Next, l 00 uL of glutathione beads (Sigma) at 
a 30% (w/v) slurry were added to the aliquots and rotated overnight at 4°C. The beads 
were washed three times at 4°C for five minutes with 600 mM NaCl HEPES buffer 
(20 mM HEPES, 600 mM NaCl, 5 mM MgCh, 0.01 % Igepal). Afterward, the beads were 
rinsed once with l 00 mM HEPES buffer (20 mM HEPES, 100 mM NaCl, 5 mM MgCh, 
0.01% Igepal). Finally, the beads were resuspended in 150 uL of 100 mM NaCl HEPES 
buffer (20 mM HEPES, 100 mM NaCl, 5 mM MgCh, 0.01 % Igepal). The proteins bound 
to the glutathione beads were run on a 10%, SOS-PAGE gel. The gel was stained with 
Brilliant blue (Sigma) and visualized under white light. 
dUTPase Assay 
dUTPase activity was determined using the protocol described by Kremmer et al. 
(1999). First, 50 mL aliquots of the previous bacterial cultures were harvested l hour 
after induction of protein expression by centrifugation at l 0,000 r.p.m. for ten minutes. 
The pellets were resuspended in l mL buffer (20 mM HEPES, 100 mM NaCl, 5 mM 
MgCh, 0.01 % lgepal) and cells were lysed by a single fifteen second sonication. 
dUTPase activity was determined by incubating 15 uL of E. coli cell extract, 
containing 1.5 ug/uL of protein, added to 10 uL of a 10 mM dUTP (Sigma) solution 
(dUTP in 20 mM HEPES, 100 mM NaCl, 5 mM MgCh, 0.01 % lgepal) at 37°C for thirty 
minutes and one hour. The reaction was terminated by adding 7 uL of0.2 M EDTA. 
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Thin Layer Chromatography 
First, 16 uL of each sample was loaded onto a polyethyleneimine cellulose plate with 
fluorescent indicator (Sigma-Aldrich). The following were loaded on the PEI plate: 
10 mM dUMP (Sigma), 10 mM dUTP (Sigma), a mixture of 10 mM dUMP and 10 mM 
dUTP, the parental vector, and the vector containing the hwnan dUTPase form. The 
nucleotide phosphates generated by the dUTPase assay were separated by ascending 
chromatography in a buffer (0.25 M KH2P04, pH 3.5). The PEI plate was visualized with 
254nrn of UV light and photographed in Gel-Doc-It system. 
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RESULTS 
Detection of motifs in KSHV ORFl 1 and ORF54 
There are two classes of dUTPases: Class 1, which includes bacteria, fungi, 
plants, metazoans, poxviruses, retroviruses, as well as invertebrate, fish, and amphibian 
herpesviruses and Class 2, which includes mammalian herpesviruses (McGeehan et al., 
2001). The two classes both contain motifs 1, 2, 3, 4, and 5. However, Class 1 motifs are 
ordered 1, 2, 3, 4, and 5 and Class 2 motifs are arranged as 3, 1, 2, 4, and 5. Also, Class 1 
dUTPase proteins are approximately 150 amino acids long as opposed to Class 2 
dUTPase proteins which are about twice as Jong (McGeehan et al., 2001). 
In particular, gammaherpesvirus dUTPases contain the conserved motifs 1, 2, 4, 
and 5 in the C-terminal half of the protein and motif3 in the N-terminal half (McGeehan 
et al., 2001 ). A proposed model has shown that motif 3 in the N-terminal half of the 
· protein is replaced by motif 6; although, motif 3 is still present in the functional protein. 
(McGeehan et al., 2001). Thus, ifORFl 1 is a dUTPase it should contain these dUTPase­ 
like motifs. 
In order to determine whether ORFI 1 contained dUTPase-like motifs, ORFl 1 and 
ORF54 (known KSHV dUTPase; Kremmer et al., 1999) were aligned using ClustalW2. 
10 
The proteins were then manually aligned in accordance with Davidson and Stow (2005). 
ORFl l and ORF54 differ in length and the sequences needed to be manually aligned to 
show motif similarities. The sequence alignments ofKSHV ORFl l and ORF54 showed 
similarity in motifs 1, 2, 4, and 6. Both ORFl l and ORF54 contain motifs l, 2, 4 and 6. 
However, ORF54 also contains motifs 3 and 5 (Davidson & Stow, 2005). The alignment 
demonstrates that ORF 11 contains a significant amount of dUTPase-like motifs. Thus, 
ORFl l may be a dUTPase. Figure lA illustrates the sequence alignment between ORFl l 
and ORF54. In contrast, the length of each protein sequence differs substantially. ORFl l 
contains407 amino acids and ORF54 318 amino acids. This suggests ORFl l may have a 
different function which utilizes the additional amino acids. As stated previously, the 
herpesvirus dUTPases (Class 2) are about twice as long as human dUTPases (McGeehan 
et al., 2001). 
The highlighted regions show similar chemical structure between amino acids. 
Figure 18 takes a closer look at the carboxy terminus of each protein. The manual 
alignment illustrated the similarity of dUTPase motifs 1, 2, 4 and 6 between ORFl l and 
ORF54. These results suggest ORFl 1 may be a functional dUTPase. 
Cloning ofKSHV ORFl l into pGEX-5x-3 gives rise to five positive clones 
To determine the functionality ofORFl 1, the gene was first cloned and 
sequenced. The gene was amplified using PCR and cloned into pGEX-5x-3. PCR was 
performed using a pair of specific oligonucleotide primers and BCBL-1 genomic DNA 
which contains the genome KSHV. Figure 2A demonstrates the ability of the specific 
primer pair to amplify a gene with the expected size of 1.2 kbp. The gene amplified is 
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consistent with the length ofORFl 1 's nucleotide sequence (Russo et al., 1996). After 
PCR amplification, the gene was gel purified to prevent non-specific bands from 
interfering with future reactions. Figure 28 demonstrates DNA purification resulting in 
specific and intense bands for ORF! l (1.2 kbp). Gel purified ORF! 1 and pGEX were 
digested sequentially with Barn HI and Eco RI. In between each digest the DNA was 
purified. 
Figure 2C demonstrates DNA purification resulting in specific and intense bands 
for ORF! I (1.2 kbp) and pGEX (5.0 kbp) doubly digested with Barn HI and Eco RI. 
Following digestion and purification, ORF! 1 and pGEX were ligated. The ligated DNA 
was transformed into E. coli. The DNA from the resulting colonies was isolated and 
tested with a double digestion using Barn HI and Eco RI, respectively. Figure 20 
demonstrates five positive clones, pGEX-ORFl 1 clones 2, 3, 4, 6 and 7. In lanes 3,4,5, 7 
and 8 expected band sizes of5.0 kbp (pGEX) and 1.2 kbp (ORFll) were observed. 
The clones were sent for sequencing to Mclab (San Francisco, CA). Toe results 
showed clones 2 and 7 had 99% similarity and clones 3, 4, and 6 had 98% similarity to 
KSHV ORFll 's known nucleotide sequence (data not shown). Toe remaining 1 % and 
2% regions respectively, are attributed to GC rich regions that were unable to be detected. 
Due to these results, clone 2 was used for further analysis. 
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Figure 1. Sequence analysis of KSHV ORF 11 and ORF 54. Sequence analysis of KSHV 
ORF 1 1  (putative dUTPase) and ORF 54 (dUTPase) was performed using ClustalW2. A 
manual sequence alignment was done to designate dUTPase-like motifs in ORFl 1. The 
motifs are designated within the boxes. Key: * -nucleotides are identical in all sequences 
in the alignment, : -conserved substitutions have been observed, and . -semi-conserved 
substitutions are observed. The amino acids in red (A VFPMIL W) are small and 
hydrophobic, in blue (DE) are acidic, in magenta (RK.) are basic, in green (STYHCNGQ) 
are hydroxyl + amine + basic - Q, and in gray indicate other. 
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Expression and purification ofKSHV ORFI 1 
Positive protein expression and purification was imperative to demonstrate before 
continuing to the dUTPase assay. ORFI 1 was transformed into E. coli strain BL21 and 
purified using glutathione beads. The resulting OST fusion proteins were separated on a 
10% SDS-PAOE gel. Figure 3 illustrates the expression and isolation of OST and OST 
fusion proteins: OST, OST-NdUTPase, and OST-ORFl 1, respectively. The OST protein, 
expressed from the pGEX-Sx-3 plasmid, was shown to be approximately 26kDa (lane 2). 
The OST-NdUTPase isolated protein was found to be approximately 48 kDa (lane 3) 
(Caposio et al., 2004). Finally, the OST-ORFI 1 protein was found to be approximately 
72 kDa (lane 4). The combination of OST (26 kDa) and ORFI 1 ( 46 kDa) gave the 
expected size of 72 kDa. Noted in the 10% SDS-PAOE gel are a few non-specific bands. 
These bands are likely the result of co-purification of E. coli proteins. However, 
expression of all three proteins was confirmed. 
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Figure 2. Cloning of KSHV ORFJ 1. A. PCR amplification using BCBL-1 genomic DNA 
and designated primers revealed several copies of a 1.2 kbp PCR product (ORFl I) (lane 
2). To the left is a 1 kb plus ladder (lane 1). ORFl 1 was cloned into a pGEX-Sx-3. B. 
ORFI 1 was gel purified revealing a single band of 1.2 kbp (lane 2). C. ORFl l and pGEX 
were sequentially digested with the enzymes Barn HI and Eco Rl. Following digestions 
both were purified. Intense bands are seen for ORF 11 (1.2 kbp) (lane 2) and pGEX (5.0 
kbp) (lane 3). D. The purified digests were used in a ligation and transformed into E. coli. 
The colonies obtained were grown in Luria broth including ampicillin (lOOug/uL). DNA 
was isolated and double digested with Barn HI and Eco R1 (lanes 2-9). 
15 
KSHV ORFl l is not a functional dUTPase 
After demonstrating the positive expression ofKSHV ORFI I and human 
NdUTPase, dUTPase activity was assayed by conducting a dUTPase assay and thin layer 
chromatography. OST, ORFl I, and human NdUTPase were expressed in E.coli BL21 
cells. The E. coli cell extracts were combined with dUTP and reaction buffer and 
incubated at 37°C for 30 minutes. The reaction was stopped and spotted onto a 
polyethyleneimine cellulose plate. Thin layer chromatography was used to separate the 
nucleotides in a phosphate buffer. The plate was visualized under UV light and 
photographed. Figure 4 demonstrates the dUTP hydrolysis by OST, OST-NdUTPase, and 
OST-ORFI 1.  E. coli extracts containing pGEX-5x-3 and pGST-NdUTPase served as 
negative and positive controls, respectively. The bacterial extracts expressing pGST 
demonstrated a low background level of dUTP hydrolysis due to endogenous E. coli 
dUTPase activity (lane 4) (Kremmer et al., 1999). While bacterial extracts expressing 
pGST-NdUTPase demonstrated the complete conversion of dUTP to dUMP in 30 
minutes (lane 5). In contrast, bacterial extracts expressing pGST-ORF 11 did not show 
the complete conversion of dUTP to dUMP and showed dUTP hydrolysis similar to the 
bacterial extracts expressing pGST (lane 6). Therefore, ORFI 1 is not a functional 
dUTPase. 
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Figure 3. Expression and Purification of KSHV ORF I I. pGST (lane 2), pGST­ 
NdUTPase (lane 3), and pGST-ORF 11 (lane 4) were expressed in E. coli BL21 (DE3) 
pLysS cells and purified using glutathione beads. The proteins and a rainbow molecular 
weight marker(lane I, GE Healthcare) ladder were run on a 10 % SOS-PAGE gel and 
stained with Brilliant blue. 
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Figure 4. KSHV ORFJ 1 is a nonfunctional dll1'Pase. E coli protein extracts expressing 
pGST (lane 4), pGST-NdUTPase (lane 5), and pGST-ORFI I (lane 6) were incubated 
with IO mM dUTP (Sigma) and the nucleotide phosphates generated were spotted on a 
PEI plate and separated by thin layer chromatography. Also spotted on the PEI plate were 
dUMP (lanel), dUTP (lane 2) and a mixture of both (lane 3) to be used in comparison of 
nucleotide separation. The PEI plate was visualized under 254 nm UV light. 
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DISCUSSION 
Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's 
disease are three devastating diseases. They are caused by the gammaherpesvirus 
Kaposi's sarcoma-associated herpesvirus. Although the virus was recently discovered in 
1994 and completely sequenced in 1996, there are several functions that are still 
unknown about many of the genes of the virus. As a result, there are not many therapeutic 
agents available for these lymphomas. Those that are available are nucleotide and 
non-nucleotide analogs. As previously mentioned, these include acyclovir, famciclovir, 
valacyclovir, ganciclovir, idoxuridine, trifluorothymidine, and foscamet (Studebaker et 
al., 200 I). However, herpesviruses are becoming resistant to these particular drugs 
(Studebaker et al., 2001 ). Hence, the importance of discovering new targets that can be 
used as chemotherapeutic agents. Potential targets to be used as chemotherapeutic agents 
in herpesviruses are dUTPases (Studebaker et al., 2001). 
A dUTPase is an enzyme which catalyzes the hydrolysis of dUTP to dUMP. This 
conversion is important in maintaining the ratio between dUTP and dlTP inside the cell. 
dUTP can be easily mistaken for dlTP by DNA polymerase and be misincorporated into 
the DNA of replicating genomes (Larsson et al., 1996). Cells without the enzyme have 
been shown to have elevated recombination frequencies and abnormal mutation rates. 
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This ultimately leads to DNA fragments as intermediates in DNA metabolism and finally 
apoptosis (Larsson et al., 1996). These effects demonstrate the importance of the enzyme 
in DNA replication. It also suggests that the enzyme may prove to be a significant 
chemotherapeutic target (Larsson et al., 1996). 
There are two different classes of dUTPases. The first, Class 1, is found in 
bacteria, plants, metazoans, and fungi. Also included in this class are poxviruses, 
retroviruses, adenoviruses, and invertebrate, fish and amphibian herpesviruses 
(McGeehan et al., 2001 ). The second, Class 2, is found in mammalian herpesviruses 
(McGeehan et al., 2001). Although both classes exhibit the same function, they differ 
greatly in protein sequence and structure. 
Class 1 dUTPases are about 150 amino acids in length and contain five conserved 
motifs. These motifs are termed and ordered l, 2, 3, 4, and 5 from the N-tenninus to the 
C-terrninus. Class I dUTPases are also active as trimers. In contrast, Class 2 dUTPases 
are approximately twice the size in length and contain six characteristic motifs. In 
particular, Alpha- and Gammaherpesvirinae contain the motifs termed and ordered 3, 1, 
2, 4, and 5 from the N-tenninus to the C-tenninus. In addition, they also contain motif 6. 
The difference in length and motif order has been attributed to the genetic duplication of 
a standard dUTPase coding sequence and the later loss of one copy of each motif from 
the double-length chain (McGeehan et al., 200 I). Overall, a functional dUTPase should 
at least contain motifs 1-5 (McGeehaneta/., 2001). 
In order to determine whether ORFl I contained dUTPase like motifs, ORFl l and 
ORF54 amino acid sequences were aligned using ClustalW2 (Figure IA). The results of 
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the alignment (Figure lB) showed that ORFl 1 contained dUTPase-like motifs 1, 2, 6, 
and 4. Still, it lacked conservation of motifs in the N-terminus. Also, the amino acid 
lengths between both genes differed by 89 amino acids. The ORF! I protein sequence 
contains 407 amino acids while the ORF54 contains 318 amino acids. However, the 
alignment showed a substantial number of dUTPase-like motifs; therefore ORFl 1 may 
function as a dUTPase. 
Following the identification of dUTPase-like motifs in ORFl I, the gene was 
positively cloned (Figure 2) and expressed in bacterial cells (Figure 3). Also positively 
expressed in bacterial cells, were OST and the human NdUTPase (Figure 3). 
Subsequently, the bacterial extracts of OST, OST-ORFl 1, and OST-NdUTPase were 
incubated with dUTP for 30 minutes and then spotted on a PEI plate in the dUTPase 
assay. The results of the dUTPase assay demonstrated that ORFl 1 is not a functional 
dUTPase (Figure 4), suggesting the protein has another function. 
The dUTPase assay evaluated the enzyme activity of bacterial extracts which 
expressed OST, OST-NdUTPase, and OST-ORFl 1 respectively (Figure 4). The bacterial 
extracts containing the OST plasmid did not show a complete conversion from dUTP to 
dUMP. However, it showed endogenous E. coli dUTPase activity similarly observed by 
Kremmer et al. (1999). The OST-NdUTPase (positive control) showed a complete 
conversion from dUTP to dUMP. These results were similar to the dUTPase activity of 
the human dUTPase control and ORF54 demonstrated by Kremmer et al. (1999). Finally, 
the bacterial extracts containing OST-ORF! 1 did not show a complete conversion from 
dUTP to dUMP; though, it showed endogenous E. coli dUTPase activity due to the use of 
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bacterial extracts as oppose to purified protein. 
In this experiment, we have clearly determined that ORF! I is not a functional 
dUTPase. As indicated previously, ORF! I lacked the conservation of motifs at the N­ 
terminus of the protein (Davidson & Stow, 2005). This may explain the reason ORF! 1 
did not demonstrate dUTPase activity. For that reason, its dUTPase-like motifs must 
serve an alternative function. Previous studies have shown ORFl 1 to be part of the 
tegument (Lu et al., 2004) and most recently in (Rozen et al., 2008). 
Tegument proteins are encased in the region between the viral capsid and the viral 
envelope. The tegument contains a complex network of protein-protein interactions 
which includes capsid proteins, glycoproteins, and other viral and cellular proteins 
(Mettenleiter, 2002). These proteins are involved in assembly of the virion. According to 
Rozen et al. (2008), ORF! 1 was found to be a tegument protein. It was shown to interact 
with both ORF45 and ORF64 of the virus. ORF45 encodes an immediate-early protein 
and is expressed in the tegument (Zhu et al., 2006). It interacts with interferon regulatory 
factor 7 and possibly plays a role in viral entrance and exit (Zhu et al., 2006). ORF64 
encodes a large tegument protein and may function as a hub protein which recruits other 
proteins such as ORF! I and ORF45 during virion assembly (Rozen et ol., 2008). 
ORF! 1 's interaction with ORF45 and ORF64 may suggest it is expressed as an 
immediate-early gene in the lytic cycle and may play a role in virion assembly. In 
addition, ORFl l and ORF45 were both found to be expressed as primary lytic genes 
(Jenner et al., 2001). This further suggests ORFl I may be expressed as an immediate­ 
early gene. Still, it's interaction with these proteins does not offer insight into why 
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ORFI 1 contains dUTPase-like motifs. 
ORFl l was just one of the proteins to be found to have dUTPase-like motifs. 
Another protein described to have dUTPase-like motifs was HCMV's UL84 (Davidson & 
Stow, 2005). Similar to ORFl l, UL84 also lacks conservation of dUTPase motifs at the 
N-terminus of the protein. A study by Colletti et al. (2005) has shown that UL84 has 
homology to a family of helicases and demonstrates UTPase activity. However, a UTPase 
converts UTP to UDP yielding a phosphate. Thus, it is not enzymatically similar to a 
dUTPase (Davidson & Stow, 2005). 
While we have clearly demonstrated that ORFl I is not a functional dUTPase 
future experiments are needed to determine a specific function. Possible future 
experiments include the determination of the expression stage of the protein during the 
lytic cycle, determining whether ORFI l has UTPase activity, and verification of specific 
protein interactions with ORF45 and ORF64. Determining the expression stage of ORFI 1 
during the lytic cycle can offer insight as to what type of role in the virus life cycle the 
protein possesses. Immediate early proteins play a role in transcription regulation, early 
proteins play a role in DNA replication, and late proteins play a role in virion assembly 
(Knipe & Howley, 2007). Determination ofUTPase activity would offer insight on the 
protein's putative role in DNA metabolism. Finally, verification of specific protein 
interactions with ORF45 and ORF64 will confirm ORFI l's possible role in virion 
assembly. 
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